Sentinel lymph node accumulation of Lymphoseek and Tc-99m-sulfur colloid using a "2-day" protocol

Nuclear Medicine and Biology

Volumn 36, Issue 6, 2009, Pages 687-692

  Wallace, Anne M ^a,b   Hoh, Carl K ^b,c   Limmer, Karl K ^a   Darrah, Denise D ^b   Schulteis, Gery ^d   Vera, David R ^b,c  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d School of Medicine   (United States)

Author keywords

"2 Day" protocol; 99mTc DTPA mannosyl dextran; Breast cancer; Lymphoseek; Molecular imaging; Radiopharmaceutical; Sentinel lymph node biopsy

Indexed keywords

LYMPHOSEEK; MANNOSYL DEXTRAN PENTETATE TECHNETIUM TC 99M; RADIOPHARMACEUTICAL AGENT; TECHNETIUM SULFUR COLLOID TC 99M; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BREAST CANCER; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; DRUG CLEARANCE; EOSINOPHIL COUNT; FEMALE; HEART RATE; HUMAN; HUMAN TISSUE; MEAN CORPUSCULAR HEMOGLOBIN; MEAN CORPUSCULAR VOLUME; MONOCYTE; PH; SENTINEL LYMPH NODE; SHOULDER PAIN; SIDE EFFECT; THROMBOCYTE COUNT; UREA NITROGEN BLOOD LEVEL;

AGED; BREAST NEOPLASMS; DEXTRANS; FEMALE; HUMANS; INJECTIONS, INTRADERMAL; LYMPH NODES; MANNANS; MIDDLE AGED; ORGANOTECHNETIUM COMPOUNDS; PENTETIC ACID; RADIOACTIVITY; RADIOPHARMACEUTICALS; SENTINEL LYMPH NODE BIOPSY; TECHNETIUM TC 99M SULFUR COLLOID; TIME FACTORS;

EID: 67651154321     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nucmedbio.2009.04.007     Document Type: Article

References (15)

1. 99mTc]DTPA-mannosyl-dextran. J Nucl Med 42 (2001) 951-959
2. Steer C.J. In: Zakim D., and Boyer T.D. (Eds). Hepatology a textbook of liver disease (1996), W. B. Saunders, Philadelphia 149-214
3. Ellner S.J., Mendez J., Vera D.R., Hoh C.K., Ashburn W.L., and Wallace A.M. Sentinel lymph node mapping of the colon and stomach using Lymphoseek in a pig model. Ann Surg Oncol 11 (2004) 674-681
4. Wallace A.M., Hoh C.K., Vera D.R., Darrah D., and Schulteis G. Lymphoseek: a molecular radiopharmaceutical for sentinel node detection. Ann Surg Oncol 10 (2003) 531-538
5. 99mTc]DTPA-mannosyl-dextran for breast cancer sentinel node mapping. Nucl Med Biol 30 (2003) 805-810
6. Wallace A.M., Hoh C.K., Ellner S.J., Darrah D.D., Schulteis G., and Vera D.R. Lymphoseek: a molecular imaging agent for melanoma sentinel lymph node mapping. Ann Surg Oncol 14 (2007) 913-921
7. Yeung H., Cody III H.S., Turlakow A., Riedel E.R., Fey J., Gonen M., et al. Lymphoscintigraphy and sentinel node localization in breast cancer patients: a comparison between 1-day and 2-day protocols. J Nucl Med 42 (2001) 420-423
8. 99mTc]DPTA-mannosyl-dextran. Nucl Med Biol 30 (2003) 457-464
9. Linehan D.C., Hill A.D.K., Akhurst T., Yeung H., Yeh S., Tran K.N., et al. Intradermal radiocolloid and intraparenchymal blue dye injection optimize sentinel node identification in breast cancer patients. Ann Surg Oncol 6 (1999) 450-454
10. Cody H.S., and Borgen P.I. State-of-the-art approaches to sentinel node biopsy for breast cancer: study design, patient selection, technique, and quality control at Memorial Sloan-Kettering Cancer Center. Surg Oncol 8 (1999) 85-91
11. McMasters K., Wong S., Martin R.I., Chao C., Tuttle T., Noyes R., et al. Dermal injection of radioactive colloid is superior to peritumoral injection for breast cancer sentinel lymph node biopsy: results of a multiinstitutional study. Ann Surg 233 (2001) 676-687
12. Wallace A.M., Hoh C.K., Darrah D.D., Schulteis G., and Vera D.R. Sentinel lymph node mapping of breast cancer via intradermal administration of Lymphoseek. Nucl Med Biol 34 (2007) 849-853
13. Kokudo N., Vera D.R., and Makuuchi M. Clinical application of TcGSA. Nucl Med Biol 30 (2003) 845-849
14. Gulec S.A., Moffat F.L., Carroll R.G., Serafini A.N., Sfakianakis G.N., Allen L., et al. Sentinel lymph node localization in early breast cancer. J Nucl Med 39 (1998) 1388-1393
15. Chagpar A.B., Martin R.C., Scoggins C.R., Carlson D.J., Laidley A.L., El-Eid S.E., et al. Factors predicting failure to identify a sentinel lymph node in breast cancer. Surgery 138 (2005) 56-63